USP26通过稳定c-Myc促进胃癌的细胞增殖
Doudou Ren1,2, Zeqiong Cai2, Ru Zhang2
1Department of Gastroenterology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
乌比基特异性酶26 (USP26) 通过稳定c-Myc促进胃癌,推动瘤生长和新陈代谢. 针对USP26为胃癌患者提供了潜在的新疗法策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 胃癌是全球癌症死亡的主要原因之一.
- 胃癌进展的分子机制尚未完全理解.
- 脱基因酶是新兴的治疗点,但胃癌的特定点仍然未被确定.
研究的目的:
- 为了确定一种新的二维基因酶点,用于胃癌治疗.
- 调查基特异性酶26 (USP26) 在胃癌进展中的作用.
主要方法:
- 生物信息学分析以确定USP26.
- 短发针RNA (shRNA) 在胃癌细胞中耗尽USP26.
- 西部涂抹和共同免疫沉以评估USP26-c-Myc相互作用和蛋白质稳定性.
主要成果:
- 在胃癌中,USP26的升高与患者生存率差的相关性.
- 消耗USP26抑制有氧糖解和胃癌细胞的增殖.
- USP26通过抑制其多比基因化和降解来与c-Myc相互作用和稳定.
结论:
- 通过USP26-c-Myc调节轴,USP26在胃癌中起着新的致癌作用.
- USP26稳定了关键的蛋白c-Myc,促进了瘤代谢和致癌.
- 针对USP26代表了胃癌的潜在治疗策略.
更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
09:24Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells
Published on: May 9, 2020
相关概念视频
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inhibition of Cdk Activity
Mitogens and the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
